|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 19/00 | |
| A61K 39/00 | |||
| A61K 39/155 | |||
| A61K 39/295 | |||
| A61K 9/107 | |||
| A61K 9/127 | |||
| A61P 31/14 | |||
| A61P 37/04 | |||
| C07K 14/135 | |||
| C12N 15/45 | |||
| C12N 15/62 | |||
| C07K 14/005 | |||
| A61K 39/12 |
| (11) | Number of the document | 3109258 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16180926.4 |
| Date of filing the European patent application | 2008-12-23 | |
| (97) | Date of publication of the European application | 2016-12-28 |
| (45) | Date of publication and mention of the grant of the patent | 2019-01-23 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 16524 P | 2007-12-24 | US | |
| 56206 P | 2008-05-27 | US |
| (72) |
BAUDOUX, Jean-Pierre, BE
BLAIS, Normand, CA
RHEAULT, Patrick, CA
RUELLE, Jean-Loius, BE
|
| (73) |
GlaxoSmithKline Biologicals s.a.,
rue de l`Institut 89, 1330 Rixensart,
BE
ID Biomedical Corporation of Quebec, 2323 Boul. du Parc Technologique Ste Foy, Quebec G1P 4R8, CA |
| (54) | RECOMBINANT RSV ANTIGENS |
| RECOMBINANT RSV ANTIGENS |